Birmingham, West Midlands -- (SBWIRE) -- 12/04/2013 -- Value Penny Stocks issues special report on Janus Capital Group Inc (NYSE:JNS), Inteliquent Inc (NASDAQ:IQNT), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Tellabs, Inc. (NASDAQ:TLAB).
Janus Capital Group Inc (NYSE:JNS) ended its recent business day with the loss of -1.49% and closed at the price of $10.57 after opening at $10.67. The stock traded during its last trading session with the total volume of 3,868,928 shares, as compared to its average volume of 2.72 million shares. Janus Capital Group, Inc. is a publicly owned asset management holding company with approximately $167.7 billion in assets under management. It also provides retirement planning, investment planning, tax planning, investment for college, and tax planning services to its clients.
Has JNS Found The Bottom and Ready To Move Up? Find Out Here
Inteliquent Inc (NASDAQ:IQNT) remained among the day advancers and traded with volume of 3,811,869 shares in the last session, as compared to average volume of 601,697.00 shares. In comparison with 52 week range of $2.20 - $12.86, it faced lowest price of $10.76 during the last trading session whereas its day highest price was $11.25. The company’s total market capitalization is $359.47 billion, along with 32.33 million shares outstanding. Inteliquent Inc. provides voice, Internet protocol (IP) transit, and Ethernet telecommunications services primarily on a wholesale basis in the United States and internationally. The company provides its services using an all-IP network, which enables to deliver global connectivity for various media, including voice and video.
For How Long IQNT’s Gloss will Attract Investors? Find out via this report
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) showed 3,496,038 shares in volume during the last trading session, while the average trading volume remained 2.20 million shares. The stock kicked off its trading session at $4.20 and closed at $4.38 after mounting 4.29%. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Will MACK Continue To Move Higher? Find Out Here
Tellabs, Inc. (NASDAQ:TLAB) stock traded during its last trading session with the total traded volume of 3,510,828 shares versus its average volume of 9.36 million shares. The company opened its trade at the price of $2.44 and its closing price was $2.44. Tellabs, Inc. designs, develops, and supports telecommunication networking products for communication service providers in the United States and internationally. The company operates through four segments: Optical, Data, Access, and Services.
Is TLAB Buy After The Recent Price Movement? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)